Lactose (India) Ltd | 161 Cr. | 128 | 247/84.3 | 36.7 | 46.7 | 0.00 % | 12.9 % | 9.75 % | 10.0 |
MPS Pharmaa Ltd | 3.82 Cr. | 2.00 | 4.33/2.00 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
Gujarat Themis Biosyn Ltd | 4,112 Cr. | 377 | 411/192 | 92.2 | 22.8 | 0.18 % | 27.3 % | 21.7 % | 1.00 |
Gujarat Terce Laboratories Ltd | 29.7 Cr. | 40.0 | 94.9/37.2 | | 8.73 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
Gujarat Inject (Kerala) Ltd | 29.4 Cr. | 20.1 | 29.1/17.0 | 30.7 | 6.83 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
Godavari Drugs Ltd | 62.0 Cr. | 82.3 | 144/79.0 | 16.4 | 57.6 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
Glenmark Life Sciences Ltd | 60,179 Cr. | 2,132 | 2,286/1,275 | 45.2 | 314 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
Gennex Laboratories Ltd | 258 Cr. | 11.3 | 29.0/10.8 | 15.7 | 8.21 | 0.00 % | 12.5 % | 9.09 % | 1.00 |
Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 19.6/9.25 | 88.2 | 14.7 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
Fredun Pharmaceuticals Ltd | 572 Cr. | 1,212 | 1,340/635 | 24.4 | 299 | 0.06 % | 18.9 % | 15.8 % | 10.0 |
Fervent Synergies Ltd | 119 Cr. | 23.8 | 32.0/15.0 | 36.4 | 11.1 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
Fermenta Biotech Ltd | 1,070 Cr. | 364 | 449/219 | 10.2 | 123 | 0.69 % | 23.0 % | 24.9 % | 5.00 |
Fabino Enterprises Ltd | 5.46 Cr. | 26.0 | 39.0/22.8 | 42.0 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
Evoq Remedies Ltd | 9.19 Cr. | 3.69 | 9.28/2.11 | 102 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
Everest Organics Ltd | 409 Cr. | 421 | 477/112 | 65.9 | 72.0 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
Entero Healthcare Solutions Ltd | 5,022 Cr. | 1,154 | 1,584/1,078 | 49.0 | 396 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
Murae Organisor Ltd | 131 Cr. | 0.64 | 1.24/0.48 | 8.61 | 1.02 | 0.00 % | 4.21 % | 5.69 % | 1.00 |
Dipna Pharmachem Ltd | 52.1 Cr. | 21.7 | 26.3/6.40 | 53.7 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
Decipher Labs Ltd | 10.5 Cr. | 10.4 | 18.4/9.61 | | 22.6 | 0.00 % | 28.4 % | 22.7 % | 10.0 |
Coral Laboratories Ltd | 189 Cr. | 529 | 961/443 | 10.2 | 563 | 0.28 % | 17.4 % | 13.1 % | 10.0 |
Concord Drugs Ltd | 68.6 Cr. | 68.6 | 71.0/26.1 | 176 | 34.1 | 0.00 % | 4.83 % | 0.88 % | 10.0 |
Colinz Laboratories Ltd | 18.6 Cr. | 40.6 | 88.7/37.9 | 38.7 | 20.7 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
Cian Healthcare Ltd | 9.87 Cr. | 3.95 | 6.00/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
Chemo Pharma Laboratories Ltd | 17.8 Cr. | 119 | 154/59.6 | | 87.6 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
Checkpoint Trends Ltd | 22.8 Cr. | 41.8 | 45.4/8.35 | 254 | 1.02 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
Chandra Bhagat Pharma Ltd | 33.2 Cr. | 44.0 | 80.0/0.00 | 46.8 | 39.7 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
Brawn Biotech Ltd | 6.24 Cr. | 20.8 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
Blue Jet Healthcare Ltd | 12,438 Cr. | 717 | 1,028/464 | 34.7 | 65.3 | 0.17 % | 39.8 % | 30.2 % | 2.00 |
Bharat Immunological & Biological Corporation Ltd | 94.6 Cr. | 21.9 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
Beryl Drugs Ltd | 12.3 Cr. | 24.3 | 46.0/17.4 | 53.6 | 18.7 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
BDH Industries Ltd | 229 Cr. | 398 | 418/241 | 24.0 | 119 | 1.13 % | 17.8 % | 14.2 % | 10.0 |
Bacil Pharma Ltd | 50.2 Cr. | 35.0 | 62.6/23.7 | 45.3 | 17.7 | 0.00 % | 3.05 % | 3.00 % | 10.0 |
Aurobindo Pharma Ltd | 64,125 Cr. | 1,094 | 1,584/994 | 18.9 | 557 | 0.41 % | 14.2 % | 11.1 % | 1.00 |
Auro Laboratories Ltd | 149 Cr. | 240 | 303/170 | 217 | 69.0 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
Anuh Pharma Ltd | 883 Cr. | 88.2 | 123/74.0 | 19.2 | 32.5 | 1.70 % | 17.2 % | 13.4 % | 5.00 |
ANG Lifesciences India Ltd | 42.7 Cr. | 32.7 | 56.8/21.0 | | 51.2 | 0.00 % | 4.12 % | 14.4 % | 10.0 |
Acutaas Chemicals Ltd | 11,806 Cr. | 1,442 | 1,530/727 | 62.4 | 160 | 0.10 % | 19.9 % | 16.0 % | 5.00 |
Amerise Biosciences Ltd | 4.76 Cr. | 0.72 | 1.45/0.66 | 95.2 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
Ambalal Sarabhai Enterprises Ltd | 241 Cr. | 31.5 | 68.0/30.0 | 12.8 | 18.3 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
Adline Chem Lab Ltd | 10.5 Cr. | 18.0 | 26.0/9.40 | | 2.55 | 0.00 % | % | % | 10.0 |
Achyut Healthcare Ltd | 126 Cr. | 5.34 | 6.25/2.82 | 229 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
Abbott India Ltd | 65,831 Cr. | 30,980 | 37,000/25,260 | 45.3 | 1,992 | 1.53 % | 46.2 % | 35.7 % | 10.0 |
Aarti Pharmalabs Ltd | 8,392 Cr. | 926 | 972/550 | 31.5 | 220 | 0.54 % | 17.4 % | 14.5 % | 5.00 |
Aarey Drugs & Pharmaceuticals Ltd | 212 Cr. | 73.4 | 75.7/31.3 | 51.0 | 48.8 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
Zota Health Care Ltd | 4,616 Cr. | 1,522 | 1,549/535 | | 78.1 | 0.07 % | 17.0 % | 36.0 % | 10.0 |
Wockhardt Ltd | 24,654 Cr. | 1,518 | 1,870/915 | | 268 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
Wanbury Ltd | 853 Cr. | 260 | 330/154 | 19.8 | 18.1 | 0.00 % | 34.9 % | 70.0 % | 10.0 |
Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.11 % | % | 2.00 |
Venus Remedies Ltd | 604 Cr. | 453 | 568/270 | 12.9 | 420 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
Unichem Laboratories Ltd | 3,555 Cr. | 506 | 950/483 | 28.4 | 348 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
TTK Healthcare Ltd | 1,670 Cr. | 1,188 | 1,795/991 | 24.8 | 754 | 0.84 % | 9.26 % | 6.89 % | 10.0 |
Torrent Pharmaceuticals Ltd | 1,20,809 Cr. | 3,566 | 3,790/2,886 | 59.8 | 224 | 0.90 % | 27.0 % | 26.5 % | 5.00 |
Themis Medicare Ltd | 1,118 Cr. | 122 | 317/98.0 | | 43.7 | 0.41 % | 10.4 % | 7.65 % | 1.00 |
Syncom Formulations (India) Ltd | 1,690 Cr. | 18.0 | 26.8/14.1 | 29.7 | 3.62 | 0.00 % | 18.7 % | 15.6 % | 1.00 |
Cohance Lifesciences Ltd | 37,556 Cr. | 980 | 1,360/856 | 107 | 66.6 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
Suven Life Sciences Ltd | 5,123 Cr. | 225 | 303/102 | | 5.04 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
Sun Pharmaceuticals Industries Ltd | 3,87,901 Cr. | 1,617 | 1,960/1,553 | 33.8 | 301 | 0.99 % | 20.2 % | 16.9 % | 1.00 |
Solara Active Pharma Sciences Ltd | 3,021 Cr. | 678 | 886/441 | 123 | 304 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
SMS Pharmaceuticals Ltd | 2,570 Cr. | 291 | 398/175 | 36.6 | 75.9 | 0.14 % | 12.2 % | 11.0 % | 1.00 |
SMS Lifesciences India Ltd | 361 Cr. | 1,199 | 1,690/956 | 20.9 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
Shilpa Medicare Ltd | 8,093 Cr. | 828 | 1,003/530 | 63.0 | 243 | 0.12 % | 7.82 % | 4.21 % | 1.00 |
Sequent Scientific Ltd | 4,569 Cr. | 183 | 241/111 | 151 | 28.1 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
Sanofi India Ltd | 11,669 Cr. | 5,067 | 7,400/4,146 | 32.7 | 340 | 2.31 % | 49.2 % | 47.2 % | 10.0 |
RPG Life Sciences Ltd | 3,921 Cr. | 2,380 | 2,977/1,772 | 37.9 | 321 | 0.84 % | 32.8 % | 25.5 % | 8.00 |
Procter & Gamble Health Ltd | 10,408 Cr. | 6,270 | 6,739/4,863 | 34.6 | 323 | 1.97 % | 47.8 % | 36.4 % | 10.0 |
Pharmaids Pharmaceuticals Ltd | 206 Cr. | 58.5 | 87.5/31.9 | | 16.8 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
Pfizer Ltd | 23,871 Cr. | 5,218 | 6,180/3,701 | 35.3 | 922 | 0.68 % | 21.6 % | 16.4 % | 10.0 |
Par Drugs & Chemicals Ltd | 133 Cr. | 108 | 348/81.0 | 9.41 | 80.4 | 0.00 % | 19.5 % | 14.5 % | 10.0 |
Panacea Biotec Ltd | 2,635 Cr. | 430 | 582/259 | | 136 | 0.00 % | 4.68 % | 5.03 % | 1.00 |
Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
Orchid Pharma Ltd | 3,601 Cr. | 710 | 1,998/604 | 42.3 | 250 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
Neuland Laboratories Ltd | 20,196 Cr. | 15,741 | 18,100/10,060 | 153 | 1,188 | 0.08 % | 18.7 % | 14.8 % | 10.0 |
Nectar Lifescience Ltd | 353 Cr. | 15.8 | 55.0/13.0 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
Natco Pharma Ltd | 15,344 Cr. | 857 | 1,618/660 | 9.04 | 425 | 0.70 % | 32.8 % | 28.0 % | 2.00 |
Morepen Laboratories Ltd | 2,944 Cr. | 53.7 | 96.1/41.7 | 31.8 | 21.1 | 0.36 % | 15.1 % | 11.8 % | 2.00 |
Marksans Pharma Ltd | 7,837 Cr. | 173 | 359/165 | 22.4 | 54.4 | 0.46 % | 20.0 % | 16.8 % | 1.00 |
Mangalam Drugs and Organics Ltd | 119 Cr. | 75.2 | 142/65.5 | | 93.9 | 0.00 % | 8.20 % | 4.76 % | 10.0 |
Lyka Labs Ltd | 355 Cr. | 99.3 | 177/90.2 | 47.3 | 29.0 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
Lupin Ltd | 93,333 Cr. | 2,043 | 2,403/1,774 | 25.2 | 377 | 0.59 % | 21.3 % | 20.6 % | 2.00 |
Lincoln Pharmaceuticals Ltd | 1,110 Cr. | 554 | 980/499 | 12.9 | 335 | 0.32 % | 17.6 % | 13.0 % | 10.0 |
Laurus Labs Ltd | 48,371 Cr. | 896 | 923/423 | 94.9 | 84.6 | 0.13 % | 9.47 % | 7.75 % | 2.00 |
Kwality Pharmaceuticals Ltd | 1,025 Cr. | 988 | 1,235/596 | 23.6 | 256 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
Krebs Biochemicals & Industries Ltd | 162 Cr. | 75.4 | 129/63.6 | | 67.8 | 0.00 % | 30.1 % | % | 10.0 |
Kopran Ltd | 860 Cr. | 178 | 358/154 | 24.6 | 107 | 1.68 % | 9.75 % | 7.64 % | 10.0 |
Kilitch Drugs (India) Ltd | 629 Cr. | 360 | 500/265 | 22.5 | 116 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
Jubilant Pharmova Ltd | 17,878 Cr. | 1,122 | 1,310/802 | 36.8 | 393 | 0.45 % | 9.54 % | 9.55 % | 1.00 |
J B Chemicals & Pharmaceuticals Ltd | 26,620 Cr. | 1,700 | 1,998/1,303 | 38.8 | 221 | 0.91 % | 25.8 % | 20.1 % | 1.00 |
Jagsonpal Pharmaceuticals Ltd | 1,602 Cr. | 240 | 328/152 | 37.6 | 36.1 | 1.04 % | 23.0 % | 18.6 % | 2.00 |
Ipca Laboratories Ltd | 33,357 Cr. | 1,315 | 1,758/1,168 | 37.3 | 274 | 0.30 % | 14.7 % | 12.8 % | 1.00 |
IOL Chemicals & Pharmaceuticals Ltd | 3,398 Cr. | 116 | 122/57.5 | 32.3 | 57.5 | 0.69 % | 8.86 % | 6.13 % | 2.00 |
Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
Ind-Swift Laboratories Ltd | 777 Cr. | 106 | 149/67.2 | 35.2 | 194 | 0.00 % | 3.47 % | 3.50 % | 10.0 |
Indoco Remedies Ltd | 2,759 Cr. | 299 | 384/190 | | 111 | 0.07 % | 0.49 % | 7.02 % | 2.00 |
Hikal Ltd | 3,174 Cr. | 257 | 465/245 | 50.2 | 102 | 0.54 % | 9.85 % | 7.38 % | 2.00 |
Hester Biosciences Ltd | 1,772 Cr. | 2,083 | 2,786/1,243 | 47.1 | 369 | 0.34 % | 9.71 % | 9.18 % | 10.0 |
Gufic BioSciences Ltd | 3,703 Cr. | 369 | 504/285 | 60.6 | 60.0 | 0.03 % | 13.0 % | 12.3 % | 1.00 |
Granules India Ltd | 12,966 Cr. | 534 | 628/412 | 27.2 | 153 | 0.28 % | 15.1 % | 13.9 % | 1.00 |
Glenmark Pharmaceuticals Ltd | 60,179 Cr. | 2,132 | 2,286/1,275 | 45.2 | 314 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
Glaxosmithkline Pharmaceuticals Ltd | 46,993 Cr. | 2,774 | 3,516/1,921 | 49.6 | 115 | 1.51 % | 63.2 % | 46.9 % | 10.0 |
Gland Pharma Ltd | 33,301 Cr. | 2,021 | 2,131/1,200 | 29.3 | 592 | 0.89 % | 15.8 % | 11.6 % | 1.00 |
FDC Ltd | 7,544 Cr. | 463 | 604/359 | 28.0 | 140 | 1.08 % | 15.9 % | 11.8 % | 1.00 |
ERIS Lifesciences Ltd | 22,827 Cr. | 1,676 | 1,910/1,097 | 59.0 | 210 | 0.44 % | 12.2 % | 12.9 % | 1.00 |
Dr Reddys Laboratories Ltd | 1,09,893 Cr. | 1,317 | 1,406/1,020 | 19.3 | 402 | 0.61 % | 22.7 % | 18.0 % | 1.00 |
Dishman Carbogen Amcis Ltd | 4,135 Cr. | 264 | 308/161 | 34.8 | 372 | 0.00 % | 2.44 % | 0.34 % | 2.00 |
Cipla Ltd | 1,27,189 Cr. | 1,575 | 1,702/1,310 | 23.6 | 386 | 0.83 % | 22.7 % | 17.8 % | 2.00 |
Caplin Point Laboratories Ltd | 17,069 Cr. | 2,246 | 2,641/1,551 | 30.2 | 375 | 0.27 % | 25.8 % | 21.7 % | 2.00 |
Brooks Laboratories Ltd | 468 Cr. | 159 | 203/95.6 | 231 | 33.3 | 0.00 % | 9.90 % | 12.2 % | 10.0 |
Bliss GVS Pharma Ltd | 1,610 Cr. | 152 | 191/105 | 15.1 | 99.7 | 0.33 % | 11.7 % | 8.36 % | 1.00 |
Biofil Chemicals & Pharmaceuticals Ltd | 72.0 Cr. | 44.3 | 92.0/40.4 | 25.8 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
Biocon Ltd | 48,826 Cr. | 365 | 406/291 | 135 | 180 | 0.14 % | 6.25 % | 4.76 % | 5.00 |
Beta Drugs Ltd | 1,854 Cr. | 1,836 | 2,215/1,430 | 40.5 | 195 | 0.00 % | 27.3 % | 25.8 % | 10.0 |
Bal Pharma Ltd | 144 Cr. | 90.3 | 141/76.3 | 20.1 | 48.6 | 1.33 % | 10.1 % | 9.66 % | 10.0 |
Bafna Pharmaceuticals Ltd | 277 Cr. | 117 | 118/67.8 | 27.5 | 35.8 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
Astrazeneca Pharma India Ltd | 22,509 Cr. | 9,004 | 10,691/6,220 | 106 | 308 | 0.36 % | 33.4 % | 23.6 % | 2.00 |
Amrutanjan Health Care Ltd | 2,188 Cr. | 757 | 843/544 | 40.1 | 113 | 0.61 % | 22.4 % | 16.5 % | 1.00 |
Alpa Laboratories Ltd | 200 Cr. | 95.0 | 145/85.0 | 7.59 | 86.4 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
Alkem Laboratories Ltd | 65,139 Cr. | 5,448 | 6,440/4,492 | 28.6 | 1,002 | 0.83 % | 20.4 % | 19.4 % | 2.00 |
Alembic Pharmaceuticals Ltd | 18,605 Cr. | 946 | 1,304/725 | 31.4 | 264 | 1.16 % | 13.0 % | 11.4 % | 2.00 |
Albert David Ltd | 459 Cr. | 803 | 1,572/763 | 72.9 | 688 | 0.62 % | 6.45 % | 4.39 % | 10.0 |
Ajanta Pharma Ltd | 32,222 Cr. | 2,579 | 3,464/2,022 | 34.6 | 303 | 1.09 % | 32.4 % | 24.9 % | 2.00 |
Advanced Enzyme Technologies Ltd | 3,789 Cr. | 339 | 571/258 | 27.7 | 127 | 1.54 % | 13.1 % | 9.54 % | 2.00 |
Aarti Drugs Limited | 4,685 Cr. | 510 | 575/312 | 26.2 | 136 | 0.20 % | 13.5 % | 13.0 % | 10.0 |
Industry Average | 19,110.52 Cr | 1,200.33 | | 51.05 | 193.71 | 0.32% | 16.39% | 15.08% | 6.18 |